Database Update: Pharmaceutical Drug Import to Russia (February 2017)
In January and February 2017, Russia imported 63.7 bln RUB worth of ready-made drugs (free circulation prices) and 14.5 bln RUB worth of in-bulk drugs, which are 4% and 51% higher than those of the same period of 2016, respectively. In monetary terms, the total import of pharmaceutical drugs has increased by 11% over the first two months of 2017.
The February performance does not seem that positive, though, as Russia imported 33.6 bln RUB worth of ready-made drugs, which is 7% lower than that of the same period of 2016. However, this can be explained by the increased activity of the importers in January. In physical terms, the import of ready-made drugs in January and February amounted to around 275.4 mln units, which is 3% higher than that of the same period of 2016. Despite the large increase in in-bulk imports, the total import of pharmaceuticals amounted to 5.83 bln minimum dosage units (MDU), with the long-term growth rate being negative (-3%).
Between January and February 2017, 95.4% of all imports of ready-made and in-bulk drugs was payed for in rubles, which is 1.4% higher than last year. The number of payments in dollars and euros has fallen, with only 4.1% of all payments. While in 2016 Russia imported from 50 countries, between January and February 2017 the number dropped to 48. However, the leaders are still the same, with Germany (17% of the import in monetary terms) and the Netherlands (11.1%).
Read more about pharmaceutical drug import to Russia (January performance) here: http://rncph.com/news/17_02_2017
Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance, RUB (January 2016 – February 2017)